---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-039574"
form_type: "8-K"
ticker: "ASBP"
cik: "0001847345"
company_name: "Aspire Biopharma Holdings, Inc."
filed_at: "2024-10-04T23:59:59+00:00"
generated_at: "2026-05-30T20:42:18.242581+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# PowerUp Acquisition Corp. agrees to pay sponsor $1M fee upon closing of Aspire Biopharma deal

## Summary
- Sponsor SRIRAMA Associates to receive $1M modified promissory note fee upon successful closing of Aspire Biopharma business combination.
- Original $2M fee from terminated Visiox BCA replaced by this $1M fee.
- Fee included as Purchaser Expenses in the Aspire BCA dated August 26, 2024.
- Agreement dated October 2, 2024 between SPAC and Sponsor.

## SEC filing metadata
- accession: 0001493152-24-039574
- form_type: 8-K
- ticker: ASBP
- cik: 0001847345
- company_name: Aspire Biopharma Holdings, Inc.
- filed_at: 2024-10-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847345/000149315224039574/0001493152-24-039574-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847345/000149315224039574/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-039574
- JSON: https://secwatch.observer/filing/0001493152-24-039574.json
- Plain text: https://secwatch.observer/filing/0001493152-24-039574.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.